Stemming Colorectal Cancer Growth and Metastasis: HOXA5 Forces Cancer Stem Cells to Differentiate

Si Hui Tan1, Nick Barker2

  • 1Institute of Medical Biology, 8A Biomedical Grove, 06-06 Immunos, 138648 Singapore, Singapore.

Cancer Cell
|December 19, 2015
PubMed

Insights

Targeting colorectal cancer stem cells is crucial. A new study shows inducing HOXA5 expression can inhibit Wnt signaling, promoting cancer stem cell differentiation for effective treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Stem Cell Research

Background:

  • Wnt signaling is a key driver of colorectal cancer stem cells.
  • Current therapeutics lack effectiveness against these specific cancer stem cells and their pathways.

Purpose of the Study:

  • To identify a novel therapeutic strategy targeting colorectal cancer stem cells.
  • To investigate the role of HOXA5 expression in cancer stem cell differentiation and Wnt signaling inhibition.

Main Methods:

  • Utilized a therapeutic intervention targeting colorectal cancer stem cells.
  • Focused on inducing HOXA5 expression.
  • Investigated Wnt signaling pathway inhibition.

Main Results:

  • The intervention selectively induced cancer stem cell differentiation.
  • HOXA5 expression was linked to Wnt signaling inhibition.
  • Demonstrated a promising approach for colorectal cancer treatment.

Conclusions:

  • HOXA5-mediated Wnt signaling inhibition offers a potential therapeutic avenue for colorectal cancer.
  • Targeting cancer stem cell differentiation is a viable strategy.
  • Further research into this pathway could lead to improved treatments.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Metastasis02:30

Metastasis

3.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.7K